About Us

Recordati Rare Diseases Inc. (RRD) is a biopharmaceutical company committed to providing often overlooked orphan therapies to the underserved rare disease communities of the United States. Recordati Rare Diseases and our sister company, Orphan Europe, are part of the rare disease business within the Recordati Group, a public international pharmaceutical company committed to the research and development of new specialties with a focus on treatments for rare diseases.

Recordati Rare Diseases’ mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.

Recordati Rare Diseases focuses on inborn errors of metabolism. We began marketing products to treat rare diseases in 2013. The U.S. Food and Drug Administration (FDA) has granted five of our products orphan drug designation. For a full list of our products please click here.

The company’s U.S. corporate headquarters is located in Lebanon, NJ, with global headquarter offices located in Milan, Italy.